• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 6-K filed by Cuprina Holdings (Cayman) Limited

    5/8/25 1:00:25 PM ET
    $CUPR
    Military/Government/Technical
    Consumer Discretionary
    Get the next $CUPR alert in real time by email
    6-K 1 form6-k.htm 6-K

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    FORM 6-K

     

    REPORT OF FOREIGN PRIVATE ISSUER

    PURSUANT TO RULE 13a-16 OR 15d-16

    UNDER THE SECURITIES EXCHANGE ACT OF 1934

     

    For the month of May 2025

     

    Commission File Number: 001-42288

     

    Cuprina Holdings (Cayman) Limited

    (Registrant’s Name)

     

    c/o Blk 1090 Lower Delta Road #06-08

    Singapore 169201

    (Address of Principal Executive Offices)

     

    Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

     

    Form 20-F ☒   Form 40-F ☐

     

    Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐

     

    Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐

     

     

     

     

     

     

    Entry into a Material Definitive Agreement.

     

    As previously disclosed, on April 11, 2025, Cuprina Holdings (Cayman) Limited (the “Company”) (Nasdaq: CUPR), consummated its initial public offering (the “IPO”) of 3,000,000 Class A ordinary shares, par value par value $0.001 per share (each, a “Class A Ordinary Share” and the Class A Ordinary Shares sold in the IPO are hereafter referred as the “IPO Shares”). The Company has also granted the underwriters a 45-day option to purchase up to an additional 450,000 Class A Ordinary Shares to cover over-allotments (the “Over-Allotment Shares”), if any (the “Over-Allotment Option”).

     

    On May 8, 2025, the Company issued and sold to the underwriter 450,000 Class A Ordinary Shares at a price of $4.00 per share, pursuant to the full exercise of the Over-Allotment Option, resulting in additional gross proceeds of approximately $1,800,000. As a result, the Company has raised aggregate gross proceeds of $13,800,000 in the IPO, including the exercise of the Over-Allotment Option, prior to deducting underwriting discounts and commissions and estimated offering expenses payable by the Company.

     

    The Company issued a press release announcing the issuance and sale of the Over-Allotment Shares on May 8, 2025. A copy of the press release is furnished herewith as Exhibit 99.1 and is incorporated by reference herein.

     

    This report does not constitute an offer to sell, or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or jurisdiction.

     

    Financial Statements and Exhibits.

     

    The following exhibits are being filed herewith:

     

    Exhibit No.   Description
    99.1   Press Release on pricing, dated May 8, 2025.

     

    2

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

     

      Cuprina Holdings (Cayman) Limited
       
      By: /s/ David Quek Yong Qi
      Name: David Quek Yong Qi
      Title: Director and Chief Executive Officer
         
    Date: May 8, 2025    

     

    3

     

    Get the next $CUPR alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CUPR

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $CUPR
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Cuprina Holdings Announces Closing of Underwriter's Over-Allotment Option in Connection with Initial Public Offering

      SINGAPORE, May 08, 2025 (GLOBE NEWSWIRE) -- Cuprina Holdings (Cayman) Limited (NASDAQ:CUPR) ("Cuprina" or "the Company"), a biomedical and biotechnology company dedicated to the development and commercialization of products for the management of chronic wounds and infertility, as well as cosmeceuticals for the health and beauty sector, today announced that it closed the sale of an additional 450,000 Class A ordinary shares of the Company, pursuant to the full exercise of the underwriter's over-allotment option granted in connection with the Company's initial public offering ("IPO", together with such over-allotment closing, the "Offering"), at the IPO price of $4.00 per share, less underwr

      5/8/25 1:05:00 PM ET
      $CUPR
      Military/Government/Technical
      Consumer Discretionary
    • Cuprina Holdings Announces Completion, Receipt of Certification and License, for IVF Media Production Facility Built in Collaboration with Ferti-Craft Pte Ltd.

      SINGAPORE, May 05, 2025 (GLOBE NEWSWIRE) -- Cuprina Holdings (Cayman) Limited (NASDAQ:CUPR) ("Cuprina" or "the Company"), a biomedical and biotechnology company dedicated to the development and commercialization of products for the management of chronic wounds and infertility, as well as cosmeceuticals for the health and beauty sector, today announced it had, on April 6, 2025, completed construction of, and obtained ISO 13485 certification and a dealer license for, an operational in-vitro fertilization ("IVF") media production facility in Singapore. The ISO 13485 certification, which validates that Cuprina's quality management system at the facility meets internationally agreed standards

      5/5/25 10:40:00 AM ET
      $CUPR
      Military/Government/Technical
      Consumer Discretionary

    $CUPR
    SEC Filings

    See more
    • SEC Form 6-K filed by Cuprina Holdings (Cayman) Limited

      6-K - Cuprina Holdings (Cayman) LTD (0001995704) (Filer)

      5/8/25 1:00:25 PM ET
      $CUPR
      Military/Government/Technical
      Consumer Discretionary
    • SEC Form 6-K filed by Cuprina Holdings (Cayman) Limited

      6-K - Cuprina Holdings (Cayman) LTD (0001995704) (Filer)

      5/8/25 8:00:30 AM ET
      $CUPR
      Military/Government/Technical
      Consumer Discretionary
    • SEC Form 6-K filed by Cuprina Holdings (Cayman) Limited

      6-K - Cuprina Holdings (Cayman) LTD (0001995704) (Filer)

      5/5/25 10:36:09 AM ET
      $CUPR
      Military/Government/Technical
      Consumer Discretionary